收藏切换
Synthesis and antitumor activity evaluation of dual-target inhibitors for tubulin and c-Src
收藏切换
Xian-fang QI1, Yue KANG2, Jian-guo QI2, *
Acta Pharmaceutica Sinica | 2025, 60(6) : 1778 - 1790
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(6): 1778-1790
• Original Articles •
Synthesis and antitumor activity evaluation of dual-target inhibitors for tubulin and c-Src
Full
Xian-fang QI1, Yue KANG2, Jian-guo QI2, *
Affiliations
  • 1Department of Pharmacy, Henan Provincial People′s Hospital, Zhengzhou 450003, China
  • 2Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng 475004, China
Published: 2025-06-12 doi: 10.16438/j.0513-4870.2025-0219
Outline
收藏切换

Microtubule-targeting drugs play a significant role in the treatment of metastatic and drug-resistant cancers. However, the emergence of resistance to microtubule-targeting drugs in clinical settings necessitates the development of molecules with novel modes of action and mechanisms to overcome drug resistance. The multi-target drug molecule strategy is an approach that has been developed in recent years to address complex diseases and drug resistance issues. A series of compounds based on tirbanibulin with increased Fsp3 have been prepared, which have been identified with 1H NMR, 13C NMR and MS. The antiproliferative activities have been evaluated against HeLa and HepG2 with MTT method. The effect on microtubule and cell cycle distribution of compound 22 has been evaluated with immunofluorescence and flow cytometry. IC50 of compound 22 against HeLa and HepG2 were 45 and 51 nmol·L-1. And it destroys microfilament and arrests cell cycle at G2/M. The SAR show that pyridine moiety in tirbanibulin cannot be replaced with 2-imidazolidinone. Compound 22 was identified as a lead in the further research.

2-imidazolidinone  /  biaryl  /  tubulin inhibitor  /  c-Src  /  antitumor
祁献芳, 康悦, 齐建国. 微管蛋白及c-Src双靶点抑制剂的合成与抗肿瘤活性评价. 药学学报, 2025 , 60 (6) : 1778 -1790 . DOI: 10.16438/j.0513-4870.2025-0219
Xian-fang QI, Yue KANG, Jian-guo QI. Synthesis and antitumor activity evaluation of dual-target inhibitors for tubulin and c-Src[J]. Acta Pharmaceutica Sinica, 2025 , 60 (6) : 1778 -1790 . DOI: 10.16438/j.0513-4870.2025-0219
Year 2025 volume 60 Issue 6
188
99
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0219
  • Receive Date:2025-02-28
  • Online Date:2026-09-20
  • Published:2025-06-12
Article Data
Affiliations
History
  • Received:2025-02-28
  • Revised:2025-04-25
Affiliations
    1Department of Pharmacy, Henan Provincial People′s Hospital, Zhengzhou 450003, China
    2Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng 475004, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0219
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT